 | Up a level |
Schwarzwald, A; Salmen, A; Léon Betancourt, A; Diem, L; Hammer, H; Radojewski, P; Rebsamen, M; Kamber, N; Chan, A; Hoepner, R; Friedli, C (2023). Anti-neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia - a case report and review of the literature. European journal of neurology, 30(4), pp. 1135-1147. Wiley 10.1111/ene.15648
Liebrand, Matthias; Rebsamen, M; Nakamura-Utsunomiya, A; von den Driesch, L; Köck, P; Caccia, I; Hamann, Christoph; Wiest, R; Kaess, Michael; Walther, Sebastian; Tschumi, S; Hiyama, TY; Kindler, Jochen (2023). Psychosis and catatonia in an adolescent patient with adipsic hypernatremia and autoantibodies against the subfornical organ (Unpublished). In: 20th International Congress of the European Society for Child and Adolescent Psychiatry. Copenhagen, Denmark. 29.06.-01.07.2023.
Girardin, F; Daali, Y; Gex-Fabry, M; Rebsamen, M; Roux-Lombard, P; Cerny, A; Bihl, F; Binek, J; Moradpour, D; Negro, F; Desmeules, J; Swiss Hepatitis C Cohort Study Group, (2012). Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection. Journal of viral hepatitis, 19(8), pp. 568-73. Oxford: Blackwell Science 10.1111/j.1365-2893.2011.01578.x
